PDCD1 and neoplasm: For example, blocking the negative IC molecules cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) [10] or the programmed cell death protein 1 and its ligand 1 (PD-1/PDL-1) [11] has been shown to reactivate cytotoxic immune cells and support efficient tumour rejection.